A Study to Assess Neuroendocrine Tumour (NET) Patients Currently Treated by Somatuline Autogel for History of Carcinoid Syndrome Associated With Episodes of Diarrhea

The purpose of the protocol is to to assess subject's overall satisfaction regarding control of diarrhea. The study aims to supplement results obtained through clinical trials with data obtained from a population of patients receiving treatment with Somatuline Autogel in routine practice.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Neuroendocrine Tumors Carcinoid Syndrome Chemically-Induced Disorders Drug-Related Side Effects and Adverse Reactions Neoplasms Neoplasms by Histologic Type Neoplasms, Germ Cell and Embryonal Neoplasms, Nerve Tissue Neuroectodermal Tumors Serotonin Syndrome

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Teaching Hospital Brno Bohunice, Brno, Czechia

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Out-patients 18 years of age and older, who have agreed to participate in the study
Diagnosed with a Neuroendocrine tumour (NET) and receiving treatment with Somatuline Autogel

Exclusion criteria

Subjects for whom there are reasons that may hinder the conduct of the study (patients who have difficulty expressing themselves or who are unable to complete the questionnaires, or with insufficient data in the their files will not be enrolled in the study).

Treatment and study plan

Primary outcomes

Subject's overall satisfaction regarding control of diarrhea

Time frame: Day of survey

Use of questionnaires to assess patient satisfaction (Likert scale).

Secondary outcomes

Impact on daily activities of the clinical manifestations of diarrhea

Time frame: Day of survey

Use of questionnaires to assess symptom severity and impact on patient's daily activities (CGI-S).

Sponsors and collaborators

Lead sponsor

Ipsen

Industry

Registry information

Official study title

An International, Cross Sectional, Non-interventional, Study to Assess Neuroendocrine Tumour (NET) Patients Currently Treated by Somatuline Autogel for History of Carcinoid Syndrome Associated With Episodes of Diarrhea

Acronym: SYMNET

Important dates

Study start: 2010
Primary completion: 2012
Study completion: 2012
First posted: Nov 4, 2010
Registry last updated: Nov 5, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed